Research Hub

Longevity & Anti-Aging Compounds

Longevity research has accelerated dramatically, with compounds like rapamycin, NAD+ precursors (NMN, NR), and various peptides drawing attention for their potential effects on aging biology. This hub profiles the most-researched longevity compounds, distinguishing those with substantial evidence from those with only early-stage or animal data.

Aging is a complex, multi-factorial process. No compound has been proven to extend human lifespan, though some — particularly rapamycin — have shown life-extending effects in multiple animal species. Peptide Compass provides transparent evidence ratings to help you separate well-supported research from hype.

Educational Content Only

This is not medical advice. Always consult a licensed healthcare provider before using any compound. No dosing or sourcing guidance is provided.

Mechanisms Targeted by Longevity Compounds

Longevity research focuses on several biological pathways associated with aging: mTOR signaling (targeted by rapamycin), cellular senescence, NAD+ metabolism, telomere maintenance, and growth hormone/IGF-1 pathways. Different compounds target different mechanisms.

Rapamycin inhibits the mTOR pathway, which regulates cell growth and metabolism. Caloric restriction and mTOR inhibition are among the most robust life-extension interventions in animal studies. NAD+ precursors (NMN, NR) aim to restore declining NAD+ levels associated with aging. Epithalon and similar peptides are studied for telomere effects, though human evidence is very limited.

Evidence Quality: Separating Science from Hype

Rapamycin has the strongest evidence base of any longevity compound. It extends lifespan in mice, yeast, worms, and flies, and has anti-aging effects observed in human organ transplant patients (though at immunosuppressive doses). However, no human lifespan trial has been completed — such trials would take decades.

NAD+ precursors (NMN, NR) have shown age-reversal effects in animal models and some human biomarker improvements, but long-term outcomes are unknown. GHK-Cu (copper peptide) has wound-healing and skin research but limited systemic longevity data. Epithalon and other telomere-targeting peptides have minimal human evidence.

  • •Rapamycin: Strongest animal evidence for life extension. FDA-approved as an immunosuppressant (Sirolimus), not for anti-aging. Long-term effects at anti-aging doses unknown.
  • •NAD+ Precursors (NMN, NR): Animal data shows age-reversal. Human trials show biomarker improvements. Long-term safety and efficacy not established.
  • •GHK-Cu: Copper peptide studied for skin repair and wound healing. Limited systemic longevity evidence.
  • •Epithalon: Telomere-lengthening claims based on very limited Russian research. No robust human trials.

Safety & Responsible Approach to Longevity Research

Longevity compounds are not a substitute for proven health practices. The most evidence-supported "longevity interventions" remain regular exercise, adequate sleep, a balanced diet, stress management, and routine medical care. These have far more human evidence than any peptide or supplement.

Rapamycin carries significant risks including immunosuppression, metabolic effects, and potential for impaired wound healing. Using it outside of medical supervision is dangerous. NAD+ precursors appear relatively safe in short-term studies but long-term data is limited. Many "longevity peptides" sold online are unregulated and may not contain what they claim.

Anyone interested in longevity research should work with a healthcare provider knowledgeable about aging biology. Legitimate clinical trials are the appropriate way to access investigational compounds.

Researched Compounds (30)

View All

Frequently Asked Questions

Does rapamycin extend human lifespan?

No human lifespan trial has been completed — such trials would take decades. However, rapamycin extends lifespan in multiple animal species (mice, yeast, worms, flies) and has the strongest evidence base of any longevity compound. It is FDA-approved as an immunosuppressant for organ transplant patients, but not for anti-aging use. Off-label use for longevity is being studied in clinical trials like the TAME (Targeting Aging with Metformin) and similar research programs.

Do NAD+ precursors like NMN and NR work for anti-aging?

NAD+ precursors (NMN and NR) have shown promising results in animal studies, including improvements in age-related biomarkers. Some human trials have shown NAD+ level increases and biomarker improvements, but no study has demonstrated increased lifespan in humans. Long-term safety and efficacy data are not yet available. NR is generally recognized as safe (GRAS) in the US, while NMN's regulatory status varies by country.

What is epithalon and is it proven to work?

Epithalon (also spelled Epitalon) is a synthetic peptide studied for potential telomere-lengthening effects. The research is primarily from Russian studies with very limited replication in Western clinical research. No robust, peer-reviewed human clinical trials have been published in major journals. Its evidence rating on Peptide Compass reflects this lack of quality data.

What is the most evidence-based approach to longevity?

The interventions with the strongest evidence for healthspan and potentially lifespan are lifestyle-based: regular aerobic and resistance exercise, adequate sleep (7-9 hours), a balanced diet (Mediterranean or similar patterns), stress management, maintaining social connections, and avoiding smoking and excessive alcohol. These have vastly more human evidence than any peptide, supplement, or investigational compound. Any pharmaceutical approach to longevity should be discussed with a healthcare provider.

Compare Compounds

Side-by-side analysis

Guided Pathways

Step-by-step research roadmap

Ask AI

AI research assistant

Peptide Compass provides educational content only and does not offer medical advice. All compound profiles are sourced from PubMed-indexed research. See our Editorial Policy and Medical Disclaimer.